Intranasal (IN) administration of insulin decreases appetite in humans, but the underlying mechanisms are unclear, and it is unknown whether IN insulin affects the food intake of women with obesity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.